ABBV vs WMT: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Walmart Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-19.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Walmart Inc. · Consumer Defensive
$106.73
-10.8% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(-1.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
WMT |
| Current Price |
$261.70 |
$106.73 |
| Fair Value Estimate |
$259.04 |
$95.24 |
| Upside to Fair Value |
-1.0%
|
-10.8%
|
| Market Cap |
$462.4B |
$849.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
21.3x
|
| Price / Sales |
7.2x
|
1.1x
|
| Price / FCF |
23.6x
|
62.8x
|
| Revenue Growth YoY |
+10.2%
|
+5.9%
|
| Gross Margin |
71.5%
|
25.2%
|
| Operating Margin |
29.3%
|
4.4%
|
| Return on Equity |
-136.5%
|
22.7%
|
| Dividend Yield |
2.61% |
0.92% |
| FCF Yield |
4.25%
|
1.59%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Walmart Inc. is the world's largest retailer by revenue, operating more than 10,000 stores and clubs across Walmart U.S., Walmart International, and Sam's Club, with a fast-growing e-commerce and advertising ecosystem layered on top of a grocery-led, everyday-low-price model. The business quality is high: scale and sourcing power underpin a durable cost advantage, ROE is 22.7%, and revenue grew 5…
Accumulation Zones
| Metric |
ABBV |
WMT |
| Zone Low |
$194.28 |
$71.43 |
| Zone High |
$220.18 |
$80.95 |
| In Buy Zone? |
No
|
No
|